Cost-effectiveness of screening for chronic hepatitis C infection in the United States Academic Article uri icon

Overview

MeSH Major

  • Hepatitis C, Chronic

abstract

  • Targeted screening is cost-effective when prevalence of HCV exceeds 0.84%. Prospective evaluation of a screening tool is warranted and should include comparisons with other screening strategies.

publication date

  • May 15, 2013

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/cid/cit069

PubMed ID

  • 23392392

Additional Document Info

start page

  • 1382

end page

  • 93

volume

  • 56

number

  • 10